适合使用类固醇的一般化肌痛性肌痛症患者:国际Delphi研究
Heinz Wiendl1, Hiroyuki Murai2, Pushpa Narayanaswami3
1Department of Neurology and Neurophysiology, University Medical Center, Freiburg, Breisacher Strasse 64, Freiburg 79106, Germany University of Muenster, Muenster, Germany.
Therapeutic advances in neurological disorders
|December 19, 2025
概括
这项研究建立了关于在肌痛性硬化症 (MG) 管理中少量使用口服皮质类固醇 (OCS) 的共识. 建议侧重于尽量减少OCS剂量和支持逐渐减少,反映了向更安全的治疗策略的转变.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 口服皮质类固醇 (OCS) 经常用于自身免疫性 Myasthenia Gravis (MG),通常高剂量和长时间使用.
- 长时间的OCS暴露与显著的累积不良影响有关.
- 关于MG的OCS管理,缺乏普遍的共识.
研究的目的:
- 为了在MG中适当使用OCS,达成跨国共识.
- 确定治疗策略在最小化OCS剂量和促进逐渐减少方面的作用.
- 建立在MG患者中使用OCS的最佳实践原则.
主要方法:
- 一项经过修改的Delphi研究,涉及来自8个国家的70名神经病学家/神经肌肉专家.
- 进行了两轮调查,以建立关于OCS在MG中使用的共识.
- 共识被定义为对关于OCS管理的建议陈述至少75%的同意.
主要成果:
- 在所有37个关于OCS在MG中使用的陈述上达成共识.
- 关键原则包括长期使用OCS的5毫克/天的目标.
- 生物治疗在最大限度地降低OCS剂量方面发挥着作用,需要逐渐减少的个性化方法.
结论:
- 这些发现支持了转向明智和节制地使用MG中的OCS的范式转变.
- 扩大治疗选择需要更新,基于证据的OCS管理建议.
- 该共识为优化OCS治疗,同时减轻不良影响提供了指导.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
Classification of Skeletal Muscle Relaxants
3.0K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.0K
Skeletal Muscle Relaxants: Adverse Effects
755
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
755
Skeletal Muscle Relaxants: Therapeutic Uses
856
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
856

